Hormonal Contraceptive Market Report: Trends, Forecast and Competitive Analysis to 2030
2 – 3 business days after placing order
Hormonal Contraceptive Trends and Forecast
The future of the global hormonal contraceptive market looks promising with opportunities in the combination hormonal contraceptive and progestin only markets. The global hormonal contraceptive market is expected to reach an estimated $19.8 billion by 2030 with a CAGR of 3.8% from 2024 to 2030. The major drivers for this market are growing awareness regarding hormonal contraception method in emerging economies and surge in investments by the major players for the R&D of novel contraceptive devices.
A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.
Hormonal Contraceptive by Segment
The study includes a forecast for the global hormonal contraceptive by method, hormone, and region.
Hormonal Contraceptive Market by Method [Shipment Analysis by Value from 2018 to 2030]:
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies hormonal contraceptive companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the hormonal contraceptive companies profiled in this report include-
Lucintel forecasts that pill will remain the largest segment over the forecast period due to increasing awareness about the pills.
Within this market, combination hormonal contraceptive will remain larger segment.
APAC is expected to witness the highest growth over the forecast period due to presence of large pool target population and rise in investment by key players in the region.
Features of the Global Hormonal Contraceptive Market
Market Size Estimates: Hormonal contraceptive market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
Segmentation Analysis: Hormonal contraceptive market size by method, hormone, and region in terms of value ($B).
Regional Analysis: Hormonal contraceptive market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different methods, hormones, and regions for the hormonal contraceptive market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the hormonal contraceptive market.
Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
FAQ
Q1. What is the hormonal contraceptive market size?
Answer: The global hormonal contraceptive market is expected to reach an estimated $19.8 billion by 2030.
Q2. What is the growth forecast for hormonal contraceptive market?
Answer: The global hormonal contraceptive market is expected to grow with a CAGR of 3.8% from 2024 to 2030.
Q3. What are the major drivers influencing the growth of the hormonal contraceptive market?
Answer: The major drivers for this market are growing awareness regarding hormonal contraception method in emerging economies and surge in investments by the major players for the R&D of novel contraceptive devices.
Q4. What are the major segments for hormonal contraceptive market?
Answer: The future of the hormonal contraceptive market looks promising with opportunities in the combination hormonal contraceptive and progestin only markets.
Q5. Who are the key hormonal contraceptive market companies?
Answer: Some of the key hormonal contraceptive companies are as follows:
Answer: Lucintel forecasts that pill will remain the largest segment over the forecast period due to increasing awareness about the pills.
Q7. In hormonal contraceptive market, which region is expected to be the largest in next 5 years?
Answer: APAC is expected to witness the highest growth over the forecast period due to presence of large pool target population and rise in investment by key players in the region.
Q.8 Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% customization without any additional cost.
This report answers following 11 key questions:
Q.1. What are some of the most promising, high-growth opportunities for the hormonal contraceptive market by method (pill, intrauterine device, injectable, vaginal ring, implant, and patch), hormone (combination hormonal contraceptive and progestin only), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
For any questions related to Hormonal Contraceptive Market, Hormonal Contraceptive Market Size, Hormonal Contraceptive Market Growth, Hormonal Contraceptive Market Analysis, Hormonal Contraceptive Market Report, Hormonal Contraceptive Market Share, Hormonal Contraceptive Market Trends, Hormonal Contraceptive Market Forecast, Hormonal Contraceptive Companies, write Lucintel analyst at email: [email protected]. We will be glad to get back to you soon.
Hormonal Contraceptive Trends and Forecast
The future of the global hormonal contraceptive market looks promising with opportunities in the combination hormonal contraceptive and progestin only markets. The global hormonal contraceptive market is expected to reach an estimated $19.8 billion by 2030 with a CAGR of 3.8% from 2024 to 2030. The major drivers for this market are growing awareness regarding hormonal contraception method in emerging economies and surge in investments by the major players for the R&D of novel contraceptive devices.
A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.
Hormonal Contraceptive by Segment
The study includes a forecast for the global hormonal contraceptive by method, hormone, and region.
Hormonal Contraceptive Market by Method [Shipment Analysis by Value from 2018 to 2030]:
- Pill
- Intrauterine Device
- Injectable
- Vaginal Ring
- Implant
- Patch
- Combination Hormonal Contraceptive
- Progestin Only
- North America
- Europe
- Asia Pacific
- The Rest of the World
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies hormonal contraceptive companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the hormonal contraceptive companies profiled in this report include-
- AbbVie
- Afaxys
- Teva Pharmaceuticals Industries
- Bayer
- Organon
- Pfizer
- Agile Therapeutics
- Janssen Pharmaceutical
- Lupin Pharmaceutical
- Pregna International
Lucintel forecasts that pill will remain the largest segment over the forecast period due to increasing awareness about the pills.
Within this market, combination hormonal contraceptive will remain larger segment.
APAC is expected to witness the highest growth over the forecast period due to presence of large pool target population and rise in investment by key players in the region.
Features of the Global Hormonal Contraceptive Market
Market Size Estimates: Hormonal contraceptive market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
Segmentation Analysis: Hormonal contraceptive market size by method, hormone, and region in terms of value ($B).
Regional Analysis: Hormonal contraceptive market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different methods, hormones, and regions for the hormonal contraceptive market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the hormonal contraceptive market.
Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
FAQ
Q1. What is the hormonal contraceptive market size?
Answer: The global hormonal contraceptive market is expected to reach an estimated $19.8 billion by 2030.
Q2. What is the growth forecast for hormonal contraceptive market?
Answer: The global hormonal contraceptive market is expected to grow with a CAGR of 3.8% from 2024 to 2030.
Q3. What are the major drivers influencing the growth of the hormonal contraceptive market?
Answer: The major drivers for this market are growing awareness regarding hormonal contraception method in emerging economies and surge in investments by the major players for the R&D of novel contraceptive devices.
Q4. What are the major segments for hormonal contraceptive market?
Answer: The future of the hormonal contraceptive market looks promising with opportunities in the combination hormonal contraceptive and progestin only markets.
Q5. Who are the key hormonal contraceptive market companies?
Answer: Some of the key hormonal contraceptive companies are as follows:
- AbbVie
- Afaxys
- Teva Pharmaceuticals Industries
- Bayer
- Organon
- Pfizer
- Agile Therapeutics
- Janssen Pharmaceutical
- Lupin Pharmaceutical
- Pregna International
Answer: Lucintel forecasts that pill will remain the largest segment over the forecast period due to increasing awareness about the pills.
Q7. In hormonal contraceptive market, which region is expected to be the largest in next 5 years?
Answer: APAC is expected to witness the highest growth over the forecast period due to presence of large pool target population and rise in investment by key players in the region.
Q.8 Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% customization without any additional cost.
This report answers following 11 key questions:
Q.1. What are some of the most promising, high-growth opportunities for the hormonal contraceptive market by method (pill, intrauterine device, injectable, vaginal ring, implant, and patch), hormone (combination hormonal contraceptive and progestin only), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
For any questions related to Hormonal Contraceptive Market, Hormonal Contraceptive Market Size, Hormonal Contraceptive Market Growth, Hormonal Contraceptive Market Analysis, Hormonal Contraceptive Market Report, Hormonal Contraceptive Market Share, Hormonal Contraceptive Market Trends, Hormonal Contraceptive Market Forecast, Hormonal Contraceptive Companies, write Lucintel analyst at email: [email protected]. We will be glad to get back to you soon.
1. EXECUTIVE SUMMARY
2. GLOBAL HORMONAL CONTRACEPTIVE MARKET : MARKET DYNAMICS
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. MARKET TRENDS AND FORECAST ANALYSIS FROM 2018 TO 2030
3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
3.2. Global Hormonal Contraceptive Market Trends (2018-2023) and Forecast (2024-2030)
3.3: Global Hormonal Contraceptive Market by Method
3.3.1: Pill
3.3.2: Intrauterine Device
3.3.3: Injectable
3.3.4: Vaginal Ring
3.3.5: Implant
3.4: Global Hormonal Contraceptive Market by Hormone
3.4.1: Combination Hormonal Contraceptive
3.4.2: Progestin Only
4. MARKET TRENDS AND FORECAST ANALYSIS BY REGION FROM 2018 TO 2030
4.1: Global Hormonal Contraceptive Market by Region
4.2: North American Hormonal Contraceptive Market
4.2.1: North American Hormonal Contraceptive Market by Method: Pill, Intrauterine Device, Injectable, Vaginal Ring, Implant, and Patch
4.2.2: North American Hormonal Contraceptive Market by Hormone: Combination Hormonal Contraceptive and Progestin Only
4.3: European Hormonal Contraceptive Market
4.3.1: European Hormonal Contraceptive Market by Method: Pill, Intrauterine Device, Injectable, Vaginal Ring, Implant, and Patch
4.3.2: European Hormonal Contraceptive Market by Hormone: Combination Hormonal Contraceptive and Progestin Only
4.4: APAC Hormonal Contraceptive Market
4.4.1: APAC Hormonal Contraceptive Market by Method: Pill, Intrauterine Device, Injectable, Vaginal Ring, Implant, and Patch
4.4.2: APAC Hormonal Contraceptive Market by Hormone: Combination Hormonal Contraceptive and Progestin Only
4.5: ROW Hormonal Contraceptive Market
4.5.1: ROW Hormonal Contraceptive Market by Method: Pill, Intrauterine Device, Injectable, Vaginal Ring, Implant, and Patch
4.5.2: ROW Hormonal Contraceptive Market by Hormone: Combination Hormonal Contraceptive and Progestin Only
5. COMPETITOR ANALYSIS
5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis
6. GROWTH OPPORTUNITIES AND STRATEGIC ANALYSIS
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global Hormonal Contraceptive Market by Method
6.1.2: Growth Opportunities for the Global Hormonal Contraceptive Market by Hormone
6.1.3: Growth Opportunities for the Global Hormonal Contraceptive Market by Region
6.2: Emerging Trends in the Global Hormonal Contraceptive Market
6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global Hormonal Contraceptive Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Hormonal Contraceptive Market
6.3.4: Certification and Licensing
7. COMPANY PROFILES OF LEADING PLAYERS
7.1: AbbVie
7.2: Afaxys
7.3: Teva Pharmaceuticals Industries
7.4: Bayer
7.5: Organon
7.6: Pfizer
7.7: Agile Therapeutics
7.8: Janssen Pharmaceutical
7.9: Lupin Pharmaceutical
7.10: Pregna International
2. GLOBAL HORMONAL CONTRACEPTIVE MARKET : MARKET DYNAMICS
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. MARKET TRENDS AND FORECAST ANALYSIS FROM 2018 TO 2030
3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
3.2. Global Hormonal Contraceptive Market Trends (2018-2023) and Forecast (2024-2030)
3.3: Global Hormonal Contraceptive Market by Method
3.3.1: Pill
3.3.2: Intrauterine Device
3.3.3: Injectable
3.3.4: Vaginal Ring
3.3.5: Implant
3.4: Global Hormonal Contraceptive Market by Hormone
3.4.1: Combination Hormonal Contraceptive
3.4.2: Progestin Only
4. MARKET TRENDS AND FORECAST ANALYSIS BY REGION FROM 2018 TO 2030
4.1: Global Hormonal Contraceptive Market by Region
4.2: North American Hormonal Contraceptive Market
4.2.1: North American Hormonal Contraceptive Market by Method: Pill, Intrauterine Device, Injectable, Vaginal Ring, Implant, and Patch
4.2.2: North American Hormonal Contraceptive Market by Hormone: Combination Hormonal Contraceptive and Progestin Only
4.3: European Hormonal Contraceptive Market
4.3.1: European Hormonal Contraceptive Market by Method: Pill, Intrauterine Device, Injectable, Vaginal Ring, Implant, and Patch
4.3.2: European Hormonal Contraceptive Market by Hormone: Combination Hormonal Contraceptive and Progestin Only
4.4: APAC Hormonal Contraceptive Market
4.4.1: APAC Hormonal Contraceptive Market by Method: Pill, Intrauterine Device, Injectable, Vaginal Ring, Implant, and Patch
4.4.2: APAC Hormonal Contraceptive Market by Hormone: Combination Hormonal Contraceptive and Progestin Only
4.5: ROW Hormonal Contraceptive Market
4.5.1: ROW Hormonal Contraceptive Market by Method: Pill, Intrauterine Device, Injectable, Vaginal Ring, Implant, and Patch
4.5.2: ROW Hormonal Contraceptive Market by Hormone: Combination Hormonal Contraceptive and Progestin Only
5. COMPETITOR ANALYSIS
5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis
6. GROWTH OPPORTUNITIES AND STRATEGIC ANALYSIS
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global Hormonal Contraceptive Market by Method
6.1.2: Growth Opportunities for the Global Hormonal Contraceptive Market by Hormone
6.1.3: Growth Opportunities for the Global Hormonal Contraceptive Market by Region
6.2: Emerging Trends in the Global Hormonal Contraceptive Market
6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global Hormonal Contraceptive Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Hormonal Contraceptive Market
6.3.4: Certification and Licensing
7. COMPANY PROFILES OF LEADING PLAYERS
7.1: AbbVie
7.2: Afaxys
7.3: Teva Pharmaceuticals Industries
7.4: Bayer
7.5: Organon
7.6: Pfizer
7.7: Agile Therapeutics
7.8: Janssen Pharmaceutical
7.9: Lupin Pharmaceutical
7.10: Pregna International
